🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled, multi-center, phase...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2020-04-07
Trial ID
NCT04158440
Based on the preclinical rationale for combining surufatinib with immunothe...
Status
Recruiting
Location
Sun yat-sen University Cancer Center
Start Date
2024-11-30
Trial ID
NCT06719700
This trial is an open-label, multicenter phase Ib/II clinical study to eval...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-01-27
Trial ID
NCT07281976
Treatments Being Tested
Exploring the efficacy and safety of zoledronic acid combined with neoadjuv...
Status
Active Not Recruiting
Location
Xijing hospital
Start Date
2025-03-10
Trial ID
NCT06876636
Treatments Being Tested
This study is a randomized, active-controlled, open-label clinical trial fo...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06647563
The goal of this clinical trial is to evaluate the efficacy and safety of n...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-25
Trial ID
NCT07272291
Treatments Being Tested
Esophageal squamous cell carcinoma (ESCC) is highly prevalent in China, wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07778056
Treatments Being Tested
Hepatic arterial infusion chemotherapy (HAIC) deliver high concentration of...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2020-07-28
Trial ID
NCT04217954
Treatments Being Tested
A multicenter randomized controlled study of surgery combined with neoadjuv...
Status
Recruiting
Location
Eye& ENT Hospital, Fudan University
Start Date
2024-07-09
Trial ID
NCT06235203
The objective of research is to evaluate the efficacy and safety of Toripal...
Status
Active Not Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-09-02
Trial ID
NCT05522985
Treatments Being Tested